Market News AIOpen the app

Mizuho Securities raised its target price for Gilead Sciences to $182, up from $170.

OpinionRead the original at marketscreener.com
Good for GILD

Mizuho raised its Gilead target and kept its Outperform rating, giving investors a more favorable analyst view. The story reports no new company results, so the positive signal is limited.

GILD · Gilead Sciences, Inc.

AI read · Good for GILD

The AI's read

That points to greater confidence in Gilead shares from this analyst. The story gives no new sales, profit, or product news, so the positive signal comes from opinion rather than a reported business change.

Get alerts for GILD

Follow Gilead Sciences, Inc. (GILD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for GILD
Free on the App Store and Google Play, or on the web.